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Background: Gitelman syndrome is an autosomal recessive tubulopathy characterized by hypokalemia, hypomagnesemia,
metabolic alkalosis and hypocalciuria. The majority of patients do not present with symptoms until late childhood or
adulthood, and the symptoms are generally mild. We report here the first case of Gitelman syndrome presenting with
the biological features of Fanconi syndrome and an early polyuria since the neonatal period. We discuss in this article
the atypical electrolytes losses found in our patient, as well as the possible mechanisms of severe polyuria.
Case presentation: A 6-year-old Caucasian girl was admitted via the Emergency department for vomiting, and
initial laboratory investigations found hyponatremia, hypokalemia, metabolic acidosis with normal anion gap,
hypophosphatemia, and hypouricemia. Urinalysis revealed Na, K, Ph and uric acid losses. Thus, the initial biological
profile was in favor of a proximal tubular defect. However, etiological investigations were inconclusive and the
patient was discharged with potassium chloride and phosphorus supplementation. Three weeks later, further
laboratory analysis indicated persistent hypokalemia, a metabolic alkalosis, hypomagnesemia, and hypocalciuria. We
therefore sequenced the SLC12A3 gene and found a compound heterozygosity for 2 known missense mutations.
Conclusions: Gitelman syndrome can have varying and sometimes atypical presentations, and should be suspected in
case of hypokalemic tubular disorders that do not belong to any obvious syndromic entity. In this case, the proximal
tubular dysfunction could be secondary to the severe hypokalemia. This report emphasizes the need for clinicians to
repeat laboratory tests in undiagnosed tubular disorders, especially not during decompensation episodes.
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Gitelman syndrome (GOMIM#263800) is an autosomal
recessive tubular disorder first described by Gitelman,
Graham and Welt in 1966 [1]. It is mainly associated with
inactivating mutations in the SLC12A3 gene located on
the long arm of chromosome 16 [2]. This gene encodes
the thiazide sensitive sodium chloride co-transporter
channel (NCCT) in the distal convoluted tubule. Gitelman
syndrome is characterized by hypokalemia, hypomagne-
semia, metabolic alkalosis and hypocalciuria. The majority* Correspondence: karim.bouchireb@nck.aphp.fr
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article, unless otherwise stated.of patients with Gitelman syndrome do not present with
symptoms until late childhood or adulthood, and symp-
toms such as fatigue, vomiting, dizziness, transient epi-
sodes of tetany, muscle weakness, cramps are generally
mild [3]. Compared with Bartter syndrome in which
polyuria is a predominant feature, polyuria and nocturia
are less pronounced in Gitelman syndrome [3]. We re-
port herein the observation of unusual presenting fea-
tures of a genetically confirmed Gitelman syndrome in a
6 year old girl.Case presentation
A six year old Caucasian girl was admitted via the
pediatric Emergency department with a history of fatigue
and vomiting in the previous 24 hours. She was borntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Sequence analysis of the SLC12A3 gene revealing a
compound heterozygosity for the two previsously published
mutations [4,5].
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assisted procreation. The mother’s medical history was un-
remarkable. According to the mother, the girl had had po-
lyuria and polydipsia since the neonatal period, with a
current daily water intake of 3 liters. On admission, blood
pressure was 90/60 mmHg, height was 114 cm (60th per-
centile), weight was 18 kg (25th percentile). The child had
blond hair and blue eyes. She had clinical signs of mild de-
hydration. Initial laboratory investigations revealed hypona-
tremia (128 mmol/L), severe hypokalemia (1.6 mmol/L)
with electrocardiographic changes, metabolic acidosis
(plasma bicarbonates 14 mmol/L) with normal plasma
anion gap (14 mmol/L), hypophosphatemia (1 mmol/L),
hypouricemia (90 umol/L), normal calcemia (2.26 mmol/L)
and a serum creatinine of 28 μmol/l. Urinalysis confirmed
the Na+, K + and uric acid losses with inappropriately high
Na + (25 mmol/l, fractional excretion of sodium of 3%),
K + (85 mmol/l, TTKG 30), tubular phosphate reabsorption
rate (18%), and a fractional excretion of uric acid of 30%.
Tests for proteinuria and glucosuria were negative. Urinary
calcium was not measured initially. Renal ultrasonography
showed mild bilateral ureterohydronephrosis. She was
rehydrated intravenously with potassium-containing fluid.
During hospitalization polyuria was confirmed (2-3 L/day,
4.7-7 L/1.73 m2/day). The polyuria, blond hair with blue eyes
and some features of Fanconi syndrome were suggestive
of cystinosis. However, the leucocyte cystine level was nor-
mal. The girl was discharged six days after admission with
oral potassium chloride and phosphorus supplementation.
Laboratory studies three weeks after discharge revealed
persistent hypokalemia (3 mmol/L), a tendency towards
metabolic alkalosis (HCO3− 29 mmol/L), and mild hypo-
magnesemia (0.65 mmol/L) while serum sodium and serum
phosphate were normal. Plasma renin activity was slightly
elevated (116 pg/ml). Hypocalciuria was also detected (cal-
ciuria 0.34 mmol/l and urinary creatinine 5.24 mmol/l, ratio
0.06 mmol/mmol). Clinically, the child was much less poly-
uric with urine output of 900 ml per 24 hours.
The biochemical triad of metabolic alkalosis, hypomag-
nesemia and hypocalciuria was suggestive of Gitelman syn-
drome and these findings were confirmed on two other
blood and urine analyses. We therefore sequenced the
SLC12A3 gene encoding the NCCT co-transporter and
found she was compound heterozygous for 2 known mis-
sense mutations (p.Thr304Met and p.Gly439Ser) (Figure 1)
[4,5]. At last follow-up, fourteen months after the acute
episode, the patient was clinically well, with an oral sup-
plementation of 4 meq/kg/day of potassium chloride and
5 mg/kg/day of magnesium element. She was no longer
polyuric.
Discussion
We report here the first case of Gitelman syndrome pre-
senting with the biological features of Fanconi syndromeand an early severe polyuria since the neonatal period.
In 1966 Gitelman et al. described a familial disorder in
three adult female patients who presented with occa-
sional episodes of muscle weakness and tetany [1]. Nei-
ther polyuria nor growth retardation were observed.
Hypokalemia, hypomagnesemia and hypocalciuria were
the biochemical hallmarks of the disease. Since the ini-
tial report many cases have been described and the
prevalence is estimated to be approximately 1 in 40.000
[5]. Here, we describe a very atypical clinical and bio-
logical presentation of Gitelman syndrome in a 6 year
old girl.
Most review articles and editorials present Gitelman
syndrome as a disease with a relatively mild course, mostly
discovered during routine investigations in adolescents or
adult patients [6]. Cruz et al. reported a cohort of 50
adults with Gitelman syndrome [7]. Most patients being
symptomatic, and the most common symptoms were
musculoskeletal symptoms (such as cramps, muscle weak-
ness and pain), generalized weakness and salt craving.
Polyuria was observed in half of the patients. The authors
defined polyuria as voiding at least five times during the
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to evaluate the importance of polyuria, and therefore au-
thors may have overestimated its prevalence. Regarding
polydipsia, the daily intake in their adult patient cohort
was (2.43 ± 1.28 L). Although these values are higher than
fluid intake in controls (1.89 ± 0.42 L), it does not seem to
be a very pronounced polydipsia for adult patients in
whom the acceptable threshold limit for polydipsia is 3 L.
Pathophysiologically, polyuria and polydipsia are less pro-
nounced in GS than in classic Bartter syndrome, because
only 7% of total salt reabsorption occurs in the distal tu-
bule where the NCCT cotransporter involved in Gitelman
syndrome is located. By contrast, in Bartter syndrome, the
impaired reabsorption of sodium chloride involves the
thick ascending limb of Henle which reabsorbs 30% of
filtered NaCl and participates to the generation of the
osmotic cortico-papillary gradient [3]. This trend was
described in the literature, and in the largest series of
Gitelman syndrome [8-10] polyuria was either absent at
diagnosis or was not a major symptom. In our case,
marked polyuria and polydipsia starting from the neonatal
period, with a daily intake of 3 L at the age of 6 years were
the main clinical symptoms. As polyuria significantly de-
creased after the correction of kaliemia in our child, we
hypothesized that a concentrating defect concomitant to
the severe initial hypokalemia was an aggravating factor to
the potentially mild polyuria due to sodium loss observed
in Gitelman syndrome. Indeed hypokalemia is known to
induce polydipsia and urinary concentration defect by
downregulation of aquaporin-2 [11,12].
The initial laboratory findings were more in favor of a
proximal tubular defect (sodium and potassium losses,
hypophosphatemia, renal tubular acidosis and hypourice-
mia with high fractional uric acid excretion). Although
hypophosphatemia is not common in Gitelman syndrome,
Vigano et al. showed that even if the bulk of phosphate is
reabsorbed in the proximal tubule, there was a tendency
towards renal phosphate wasting with mild to moderate
hypophosphatemia in their cohort of 12 patients with
Gitelman syndrome [13]. In our patient hypophosphate-
mia was transient suggesting the importance of a long
term follow-up of phosphate levels. The plasma acidosis
and uric acid loss found initially in our patient could also
be part of a tubular proximal defect secondary to the
hypokalemia. Indeed, tubular proteinuria has been de-
tected in patients with severe hypokalemia of different
etiologies [14] and a transitory proximal dysfunction
(tubular proteinuria, phosphaturia uricosuria and amino-
aciduria) in patients with hypokalemia associated with
renal tubular acidosis [15,16] Nevertheless, as proximal
dysfunction in distal renal tubular acidosis is corrected by
alkali and potassium supplementation, a participation of
acidosis in this dysfunction can not be excluded. Although
tubular proteinuria and aminoaciduria were not assessedin our patient, we hypothesize that the transitory proximal
dysfunction (acidosis, hypophosphatemia and hypourice-
mia) is secondary to the severe hypokalemia (1.6 mmol/l).
A few cases of Gitelman syndrome associated with
glomerular or tubulointerstitial disease have been re-
ported [17], but to date, no case associated to or with an
initial profile of Fanconi syndrome have been described.
Conclusion
Gitelman syndrome can have varying and sometimes
atypical presentations and should be suspected in case of
hypokalemic tubular disorders that do not belong to any
syndromic entity. This case report emphasizes the need
for repeated laboratory tests in undiagnosed tubular dis-
orders, especially not during decompensation episodes.
Severe transient polyuria and proximal dysfunction may
be observed in case of severe hypokaliemia and this
symptom improves after potassium supplementation.
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